How effective is targeting intensive glycaemic control for type 2 diabetes?
Separate analysis of intensive glycaemic control as a part of a multimodal treatment regimen could not be performed due to lack of data. Although it was not possible to pool quality of life data, it is conceivable that targeting intensive, compared with conventional glycaemic control, may negatively affect quality of life for patients aiming to cope with sometimes very complex and time-consuming treatment modalities and combinations.
Patients with type 2 diabetes exhibit an increased risk of cardiovascular disease and mortality compared with the background population. Observational studies report a relationship between reduced blood glucose and reduced risk of both microvascular and macrovascular complications in patients with type 2 diabetes.